glp-1 micro dose THE MICRODOSING PROGRAM GLP-1 Microdosing | Chicago Concierge
Description
Learn the science
Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform.
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Natural Results.
